Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRDS
3076
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $309K | ﹤0.01% |
+42,800
| New | +$421K |
|
3077
Choice Hotels
CHH
$5.07B
| $308K | ﹤0.01% |
2,172
-4,942
| -69% | -$711K |
|
|
MFA
3078
MFA Financial
MFA
$926M
| $308K | ﹤0.01% |
19,146
-115,214
| -86% | -$1.99M |
|
3079
Citizens
CIA
$239M
| $306K | ﹤0.01% |
71,980
-52,482
| -42% | -$237K |
|
|
AGNT
3080
AGNT Inc
AGNT
$666M
| $306K | ﹤0.01% |
14,504
-61,694
| -81% | -$1.62M |
|
|
SY
3081
So-Young International
SY
$185M
| $306K | ﹤0.01% |
154,317
-222,750
| -59% | -$532K |
|
3082
Zumiez
ZUMZ
$332M
| $306K | ﹤0.01% |
8,002
-27,914
| -78% | -$1.21M |
|
|
AFMD
3083
DELISTED
Affimed
AFMD
| $302K | ﹤0.01% |
6,902
-11,675
| -63% | -$507K |
|
3084
Enovis
ENOV
$1.68B
| $302K | ﹤0.01% |
4,397
-222,637
| -98% | -$15.9M |
|
|
BSGA
3085
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
| $302K | ﹤0.01% |
+30,000
| New | +$300K |
|
3086
FIVE9
FIVN
$2.11B
| $300K | ﹤0.01% |
2,714
-6,771
| -71% | -$788K |
|
3087
Envista
NVST
$4.44B
| $298K | ﹤0.01% |
+6,136
| New | +$283K |
|
3088
KVH Industries
KVHI
$181M
| $297K | ﹤0.01% |
32,579
-15,938
| -33% | -$143K |
|
3089
RUM Group Inc
RUM
$1.61B
| $297K | ﹤0.01% |
+25,000
| New | +$310K |
|
|
LGF.B
3090
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $296K | ﹤0.01% |
19,731
-123,647
| -86% | -$1.79M |
|
|
CSW
3091
CSW Industrials
CSW
$5.2B
| $295K | ﹤0.01% |
2,508
-15,515
| -86% | -$1.83M |
|
3092
Tigo Energy
TYGO
$145M
| $295K | ﹤0.01% |
+29,750
| New | +$294K |
|
|
NGM
3093
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $295K | ﹤0.01% |
19,371
-36,389
| -65% | -$568K |
|
3094
Anika Therapeutics
ANIK
$258M
| $293K | ﹤0.01% |
11,647
-7,199
| -38% | -$219K |
|
3095
Greenlight Captial
GLRE
$552M
| $293K | ﹤0.01% |
41,535
-27,633
| -40% | -$201K |
|
3096
Bank of N.T. Butterfield & Son
NTB
$2.43B
| $293K | ﹤0.01% |
8,149
-52,760
| -87% | -$2M |
|
|
VLTA
3097
DELISTED
Volta Inc.
VLTA
| $293K | ﹤0.01% |
+95,908
| New | +$461K |
|
|
DGNU
3098
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
| $293K | ﹤0.01% |
+30,000
| New | +$292K |
|
3099
ROBO Global Robotics & Automation Index ETF
ROBO
$1.96B
| $292K | ﹤0.01% |
5,014
+3,112
| +164% | +$189K |
|
3100
CryoPort
CYRX
$761M
| $291K | ﹤0.01% |
8,323
-41,513
| -83% | -$1.57M |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.